Human Genome Sciences Inc. (HGSI)
Q1 2012 Results Earnings Call
April 24, 2012 4:30 PM ET
Tom Watkins – President and CEO
Barry Labinger – Executive Vice President and Chief Commercial Officer
David Southwell – Executive Vice President and CFO
Dave Stump – Executive Vice President, Research and Development
Joe Schwartz – Leerink Swann
Cory Kasimov – JPMorgan
Chris Raymond – Robert Baird
Matthew Harrison – UBS
Les – ISI Group
Terence Flynn – Goldman Sachs
Charmaine Chan – RBC Capital Market
Nicholas Bishop – Cowen and Company
Jim Birchenough – BMO Capital
Laura Ekas – Canaccord
Liisa Bayko – JMP Securities
Ying Huang – Barclays
Echo He – Maxim Group
Please standby. Good day, everyone. And welcome to Human Genome Sciences’ First Quarter 2012 Financial Results Conference Call and Webcast. Please note, today’s call is being recorded.
At this time, I will turn things over to Mr. Tom Watkins, President and Chief Executive Officer of Human Genome Sciences. Please go ahead, sir.
Thank you, Operator, and good afternoon, everyone. Before we begin, I would like to point out that we will be making forward-looking statements, which are based on our current intent, belief and expectations. These statements are subject to certain risks and uncertainties, and I encourage everyone to consult our SEC filings for additional detail.
We reported our first quarter financial results earlier this afternoon and the press release that we issued, as well as several slides that we will be discussing in this call are both posted on our website and that’s
Now we do not plan to take you through the financial results in today call. Although, we will take any questions that you may have on the first quarter later in this call.